CA1016550A - 4-aryl-5-aminoalkyl-4-oxazolin-2-ones - Google Patents

4-aryl-5-aminoalkyl-4-oxazolin-2-ones

Info

Publication number
CA1016550A
CA1016550A CA183,418A CA183418A CA1016550A CA 1016550 A CA1016550 A CA 1016550A CA 183418 A CA183418 A CA 183418A CA 1016550 A CA1016550 A CA 1016550A
Authority
CA
Canada
Prior art keywords
oxazolin
aminoalkyl
aryl
ones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA183,418A
Other languages
English (en)
French (fr)
Other versions
CA183418S (en
Inventor
Elso Manghisi
Giuseppe Cascio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Luso Farmaco dItalia SpA
Original Assignee
Istituto Luso Farmaco dItalia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2811573A external-priority patent/IT1056733B/it
Application filed by Istituto Luso Farmaco dItalia SpA filed Critical Istituto Luso Farmaco dItalia SpA
Application granted granted Critical
Publication of CA1016550A publication Critical patent/CA1016550A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA183,418A 1972-10-16 1973-10-15 4-aryl-5-aminoalkyl-4-oxazolin-2-ones Expired CA1016550A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT3053672 1972-10-16
IT2811573A IT1056733B (it) 1973-08-22 1973-08-22 4 aril 5 aminoalohil 4 ossazolin 2 oni loro derivati e processi per la loro preparazione

Publications (1)

Publication Number Publication Date
CA1016550A true CA1016550A (en) 1977-08-30

Family

ID=26328766

Family Applications (1)

Application Number Title Priority Date Filing Date
CA183,418A Expired CA1016550A (en) 1972-10-16 1973-10-15 4-aryl-5-aminoalkyl-4-oxazolin-2-ones

Country Status (13)

Country Link
US (1) US3930008A (nl)
JP (1) JPS4993360A (nl)
CA (1) CA1016550A (nl)
CH (1) CH605859A5 (nl)
DE (1) DE2351948A1 (nl)
DK (1) DK135122B (nl)
ES (1) ES419632A1 (nl)
FI (1) FI57752C (nl)
FR (1) FR2202701B1 (nl)
GB (1) GB1429571A (nl)
NL (1) NL161154C (nl)
NO (1) NO140299C (nl)
SE (1) SE391717B (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123529A (en) * 1976-04-23 1978-10-31 Lilly Industries Limited Phenylpiperazine derivatives
FR2546167B2 (fr) * 1983-05-19 1985-07-12 Cortial Nouvelles amino-2 piperazino et piperidinomethyl-5 oxazolines-2, leur methode de preparation ainsi que leur application therapeutique
PT77428B (fr) * 1982-10-05 1986-02-27 Cortial Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant
CN1008735B (zh) 1984-11-02 1990-07-11 拜尔公司 以取代的氮杂茂基甲基-环丙基-甲醇衍生物为活性成分的组合物
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US6159990A (en) 1997-06-18 2000-12-12 Synaptic Pharmaceutical Corporation Oxazolidinones as α1A receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
JPS4922770A (nl) * 1972-06-22 1974-02-28

Also Published As

Publication number Publication date
FR2202701A1 (nl) 1974-05-10
NO140299B (no) 1979-04-30
NO140299C (no) 1979-08-08
NL7314147A (nl) 1974-04-18
DE2351948A1 (de) 1974-04-25
DK135122B (da) 1977-03-07
AU6121673A (en) 1975-04-10
SE391717B (sv) 1977-02-28
FI57752B (fi) 1980-06-30
ES419632A1 (es) 1976-06-16
DK135122C (nl) 1977-08-08
GB1429571A (en) 1976-03-24
NL161154B (nl) 1979-08-15
FI57752C (fi) 1980-10-10
CH605859A5 (nl) 1978-10-13
JPS4993360A (nl) 1974-09-05
FR2202701B1 (nl) 1980-01-11
NL161154C (nl) 1980-01-15
US3930008A (en) 1975-12-30

Similar Documents

Publication Publication Date Title
AU462348B2 (en) Saf-t-jet
AU467469B2 (en) Trifluoromethylmercaptoacetamindocephalosphorins
AU454372B2 (en) Childsafe actuator-overcap
AU469305B2 (en) Deipenylyl-alkanoylaminopyridine
AU475339B2 (en) S-substituted-2-thiodenosines
AU475748B2 (en) Napnthopyrans
AU470359B2 (en) Sulphamoylphenyl-imidazolidinones
CA1016550A (en) 4-aryl-5-aminoalkyl-4-oxazolin-2-ones
AU466344B2 (en) Cycloalkyllactamimides
AU468159B2 (en) 5-aroyl-furans
AU471369B2 (en) Diphenylmethoxyethylamines
AU473297B2 (en) Indolylimidoylheterocyclics
AU467526B2 (en) Pyronorifamycins
AU468236B2 (en) 2-acyl-5-nitrothiazoles
AU468599B2 (en) 15-oxasteroids
AU472554B2 (en) Isothocyanobenzoxazoles
AU485245B2 (en) Pentanorprostaglandins
AU485187B2 (en) Glutamyl-p-nitroanilide-derivative
AU473061B2 (en) 3-aminohydroxypropoxy-2-substituted-4-pyranones
AU479372B2 (en) Dl-methionyl-dl-methionine
AU451103B2 (en) 1-alkylidene-3-indenyl echanols
AU479515B2 (en) Imino-isoindolinones
AU474168B2 (en) Anilinobenzothiazoles
AU480769B2 (en) Cyanomethylthioacetylcephalosporins
AU465942B2 (en) Buhner